Papageorgiou I, Minaretzis D, Tsionou C, Michalas S
1st Department of Obstetrics and Gynecology, University of Athens, Greece.
Prostaglandins. 1991 May;41(5):487-93. doi: 10.1016/0090-6980(91)90054-j.
One hundred twenty eight women underwent midtrimester induced abortion with: 1) combined regimen of intramniotic prostaglandin (PG) F2a injection and intracervical laminaria tents (group A, 50 women), 2) intramniotic PGF2a injection only (group B, 51 women) and 3) laminaria tents followed by intracervical PGF2a tablets insertion (group C, 27 women). The mean induction-abortion time (+/- SE) was 24.9 +/- 1.7 hours for group A, 28.2 +/- 2.2 hours for group B (p greater than 0.05) and 42.1 +/- 3.4 hours for group C, significantly longer than goup A and B (p less than 0.001 and p less than 0.01 respectively). In 48 hours 98% of the patients of group A, 90% of group B (p less than 0.05) and 59% of group C (p less than 0.001) completed the abortion procedure. Parous women of group A and B presented similar induction - abortion time, while in nulliparous the use of laminaria shortened the abortion procedure significantly (p less than 0.05). The complications rate was low. In conclusion, the intracervical PGF2a insertion is a simple but very slow abortion procedure with high failure rates. The intramniotic PGF2a injection is a successful method for late midtrimester medical pregnancy termination and the concurrent use of laminaria tents shortens the abortion procedure, particularly in nulliparous, reduces the number of prostaglandins' reinjections and increases the incidence of successful abortion within 48 hours.
128名妇女在孕中期接受了人工流产,方法如下:1)羊膜腔内注射前列腺素(PG)F2a联合宫颈内放置昆布囊(A组,50名妇女);2)仅羊膜腔内注射PGF2a(B组,51名妇女);3)放置昆布囊后宫颈内插入PGF2a片剂(C组,27名妇女)。A组平均引产至流产时间(±标准误)为24.9±1.7小时,B组为28.2±2.2小时(p>0.05),C组为42.1±3.4小时,显著长于A组和B组(分别为p<0.001和p<0.01)。48小时内,A组98%的患者、B组90%的患者(p<0.05)和C组59%的患者(p<0.001)完成了流产手术。A组和B组的经产妇引产至流产时间相似,而未产妇使用昆布囊可显著缩短流产过程(p<0.05)。并发症发生率较低。总之,宫颈内插入PGF2a是一种简单但非常缓慢的流产方法,失败率高。羊膜腔内注射PGF2a是孕中期晚期药物终止妊娠的一种成功方法,同时使用昆布囊可缩短流产过程,尤其是对未产妇,减少前列腺素的再次注射次数,并增加48小时内成功流产的发生率。